Strategic communications and investor engagement for life sciences companies at pivotal moments
Putnam Insights advises emerging life sciences companies on the communications, positioning, and stakeholder strategies that support fundraising, clinical development, commercialization, reputation, and long-term growth.
We work alongside founders and executive leadership teams to define the company story, sharpen how it is communicated, and make sure it holds up across the conversations that matter most, from investors and strategic partners to media and other industry stakeholders.
Our work spans enterprise positioning, investor communications and engagement, executive preparation, media strategy, thought leadership, and milestone communications. By bringing these efforts together, we help companies communicate with greater clarity, build credibility with the audiences that matter, and create stronger alignment between where the business is today and where it is going.
What We Advise On
Rare disease demands more—and so do we. With a global footprint of approved products and a broad pipeline of investigational medicines, we are advancing
therapies that expand what patients and families can expect—today and in the years ahead.
Corporate Positioning & Reputation
Define the enterprise story, strengthen corporate reputation, prepare for the unexpected, and establish the
foundation that guides external messaging.
Investor & Capital Markets Communications
Build and manage the investor story around the business strategy, scientific opportunity, milestones, value creation, and the questions investors are most likely to ask.
External Affairs & Executive Visibility
Prepare leadership for the moments that matter: media, thought leadership, Speaking engagements, and strategic announcements.
LIFE SCIENCES LIFECYCLE
Built for the inflection points.
Communications requirements change as a life sciences company grows. The story that works in formation or seed financing may not be enough for institutional investors, clinical stakeholders, strategic partners, or the market at large
As the company evolves, the conversation with investors continues.
Communications needs change as a life sciences company grows. Putnam Insights brings senior counsel to the moments when the narrative, audience, and stakes shift.
FEATURED ENGAGEMENT
Enterprise Narrative Sprint
One strategic foundation for every stakeholder conversation.
Putnam Insights Enterprise Narrative Sprint is a focused advisory engagement for companies that need greater clarity before a financing, clinical milestone, strategic partnership, website relaunch, commercialization effort, or other critical period of growth.
A focused advisory engagement for companies that need clarity before a financing, milestone, partnership, or relaunch. Through structured discovery and executive interviews, we define the narrative, align leadership language, and translate the story into investor-ready communications.